Tamicod (Butamirate Citrate) is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection.Tamicod is also used for pre- & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.

Butamirate Citrate acts directly on the brain’s cough center to suppress cough. Butamirate Citrate is safe and non-sedating which is neither chemically nor pharmacologically  related  to  opium  alkaloids.  It  is  rapidly  and  completely  absorbed  after  oral  administration. Butamirate Citrate is extremely protein bound and plasma elimination half-life is about 13 hours. The active metabolites of Butamirate Citrate have also antitussive action.

Tamicod Syrup: 
Children (3-6 years) : 5 ml 3 times daily, 
Children (6-12 years) : 10 ml 3 times daily, 
Adolescent : 15 ml 3 times daily, 
Adult : 15 ml 4 times daily.

Hypersensitivity to the active ingredient.

Tolerance of Butamirate Citrate is good. Adverse reactions such as rash, nausea and vertigo have been observed in a few rare cases, resolving after dose reduction or treatment withdrawal.

Butamirate Citrate should not be used during the 1st trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution.

Accidental overdose with Butamirate Citrate can cause the following symptoms: drowsiness, nausea, vomiting, diarrhoea and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.

Keep away from light and moisture, store below 30°C. Keep all the medicines out of the reach of children.